undamentalytics Newsletter

Viemed Healthcare, Inc. revenue

Viemed Healthcare, Inc.'s revenue was $270m in fiscal 2025, up 20.5% on the year before. Since fiscal 2018 ($64.5m) it has grown at a compound 22.7% a year. Over the last twelve months it was $302m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Viemed Healthcare, Inc.: revenue history, annual
Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue6480131117139183224270302
Growth on the year before—+24.5%+63.6%−10.8%+18.6%+31.8%+22.5%+20.5%—
Gross profit4856807385113133155173
Gross margin74.1%69.8%61.0%62.7%61.0%61.6%59.4%57.5%57.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Equipment Sales $50.3M ▲ 62.7%
Services $24.9M ▲ 23.6%

These categories overlap or exclude eliminations, so shares aren't shown.

From Viemed Healthcare, Inc.'s 10-K filed March 4, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Viemed Healthcare, Inc. $302m 25.2% 24.5%
Docgo Inc. $295m -32.4% -13.3%
DLH Holdings Corp. $254m -29.5% -9.5%
Caredx, Inc. $497m 38.9% 18.7%
SBC Medical Group Holdings Inc $175m -6.9% —
Petmed Express Inc $169m -20.3% -13.0%

Compare with peers

Head to head: DCGO vs VMDDLHC vs VMDCDNA vs VMD

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Viemed Healthcare, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Viemed Healthcare, Inc.